FDA Flags Missing Trial Results - Top-Institutions - MDSpire

FDA Flags Missing Trial Results

Federal outreach seeks to improve compliance with ClinicalTrials.gov reporting requirements and make more complete clinical trial information publicly available

  • By

  • Kathryn Wighton

  • April 13, 2026

  • 3 min

Share

Top Institutions in Internal Medicine

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Clinical Trial Transparency
    • Regulatory Science
    • Public Health

  • #2

    Harvard University
    Harvard University

    Boston, MA

    Key Differentiators

    • Clinical Research
    • Health Policy
    • Regulatory Affairs

  • #3

    Duke University
    Duke University

    Durham, NC

    Key Differentiators

    • Clinical Trials
    • Regulatory Compliance
    • Biomedical Ethics

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Clinical Research
    • Health Policy
    • Regulatory Science

  • #5

    National Institutes of Health (NIH)
    National Institutes of Health (NIH)

    Bethesda, MD

    Key Differentiators

    • Clinical Trial Oversight
    • Regulatory Compliance
    • Biomedical Research

Original Source(s)

FDA Flags Missing Trial Results

  • by Kathryn Wighton

  • April 13, 2026

Related Content

Top 10 States With Rising Demand for Physicians

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

FDA Clears Golimumab Biosimilars

New biosimilars enter the market with pharmacy-level substitution eligibility for rheumatology and gastroenterology indications.

Top 10 States with the Lowest Costs for Running a Medical Practice

These 10 states posted some of the lowest 2026 Medicare practice expense GPCI among states that CMS treats as a single statewide locality, with broader price levels and selected malpractice or tax indicators adding context.